Skip to main content

FDA panel rejects plan to administer Pfizer's Covid booster doses to general public

Scientists continued debating the need for a third dose of the vaccines for older Americans, leaving open the possibility of other votes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.